SCHEMBL27648763

SCHEMBL27648763

COc1c(C(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc([N+](=O)[O-])c(F)c1F

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 11/20 0.53
▸ SLC6A5 Q9Y345 3/20 0.53
▸ KDM4E B2RXH2 1/20 0.52
▸ MGLL Q99685 1/20 0.51
▸ ENPP2 Q13822 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ SERPINE1 P05121 1/20 0.44
▸ NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4420325 0.73 SLC6A9 (0.73) SLC6A9SLC6A5ENPP2LMNAMAPT
SCHEMBL4427344 0.72 SLC6A9 (0.66) SLC6A9SLC6A5ENPP2KCNH2LMNA
SCHEMBL31349271 0.72 ALDH1A1 (0.50) SLC6A9SLC6A5MGLLENPP2MAPT
SCHEMBL5038044 0.72 SLC6A9 (0.65) SLC6A9SLC6A5KDM4EMGLLENPP2
SCHEMBL4425899 0.72 SLC6A9 (0.72) SLC6A9SLC6A5ENPP2KCNH2LMNA
SCHEMBL5132304 0.72 SLC6A9 (0.61) SLC6A9SLC6A5ENPP2KCNH2LMNA
SCHEMBL31349221 0.71 SLC6A9 (0.52) SLC6A9SLC6A5MGLLENPP2MAPT
SCHEMBL4420914 0.71 SLC6A9 (0.66) SLC6A9SLC6A5ENPP2KCNH2LMNA
SCHEMBL4422175 0.70 SLC6A9 (0.62) SLC6A9SLC6A5MGLLENPP2KCNH2
SCHEMBL4425815 0.70 SLC6A9 (0.62) SLC6A9SLC6A5MGLLENPP2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1867554-B Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors HOFFMANN LA ROCHE 2011-07-06 — — CN disclosed
CN-1867554-A Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors HOFFMANN LA ROCHE (CH) 2006-11-22 — — CN disclosed
Send feedback